Pharma

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Most Viewed Abstracts



Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

MediGene AG announces that its Marketing Authorisation Application for the medicinal product Veregen for the treatment of genital warts has been assessed positively by the national regulatory authorities of Germany, Austria, and Spain. This binding decision guarantees that national Marketing Authorisations in these countries will be formally granted by the authorities within the next few months. The Marketing Authorisation of Veregen in Germany, the Reference Member State in this Decentralized Procedure, shall provide the basis for additional Marketing Authorisations in other European countries via the Mutual Recognition Procedure.

Today in Marketing/Media/ROI...keeping you current

Alcon to Enter Surgical Glaucoma Market by Acquiring Optonol
Alcon, 12/15/09

Hospira Buys Infection Control Vendor
HealthDataManagement, 12/11/09

Mediware Makes Two Buys
HealthDataManagement, 12/10/09

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address